Steve Sloane
Partner @ Menlo Ventures
San Francisco, United States
Steve Sloane is a Series B investor at Menlo Ventures in San Francisco focused on Artificial Intelligence and SaaS. Steve Sloane is based out of California and currently works as a Partner for Menlo Ventures. Steve Sloane attended the Princeton University.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 47%
Last updated:
For AI agents: llms.txt
Industries Steve Sloane invests in
Stages Steve Sloane invests in
Countries Steve Sloane invests in
Investment Focus
Industry
- Artificial Intelligence 3 (20%)
- SaaS 2 (13%)
- FinTech 2 (13%)
- Logistics 2 (13%)
- Health Care 2 (13%)
Stage
- Series B 5 (33%)
- Series C 4 (27%)
- Series A 3 (20%)
- Series D 2 (13%)
- Funding Round 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Runwise is a wireless control, sensor network, and software platform to better operate heating systems. Its mission is to enable buildings to run more efficiently using intelligent and easy-to-install wireless hardware and software.The company's users can reduce heating expenses and carbon emissions thanks to the network's management ofheating and boiler systems, which also avoids under- and overheating and gives a verifiable online record of both. | $30M / Series B / Jun 09, 2025 | |
|
|
Eleos Health provides automated health tech solutions that accelerate clinicians’ decision-making via an AI-powered Speech-to-Insights system to ensure the provision of personalized and time and cost-effective care. | $60M / Series C / Jan 22, 2025 | |
|
|
Sidecar Health is an insurtech company that provides a personalized health insurance platform. Its platform offers customizable plans based on coverage needs and budget while being completely transparent about medical costs and payouts with comparable coverage and permits fast and easy transactions through a credit card to charge medical expensesupfront at the doctor's office and pharmacy of their choice, enabling consumers to get suitable and affordable health insurance plans.The company was founded in 2018 and is headquartered in El Segundo, California . | $165M / Series D / Jun 26, 2024 | |
|
|
Eleos Health provides automated health tech solutions that accelerate clinicians’ decision-making via an AI-powered Speech-to-Insights system to ensure the provision of personalized and time and cost-effective care. | $40M / Series B / Nov 08, 2023 | |
|
|
Enable is a cloud-based software platform that helps distributors, manufacturers, and retailers to calculate, plan, and accrue rebate deals precisely to drive profitable growth. The company's mission is to build an ideal business-to-business deal management solution. Its products help companies acquire, retain, and serve their customers byworking collaboratively with their trading partners using joined-up plans and incentive programs.Enable was founded in 2016 and is headquartered in San Francisco, California. | $120M / Series D / Nov 07, 2023 | |
|
|
Enable is a cloud-based software platform that helps distributors, manufacturers, and retailers to calculate, plan, and accrue rebate deals precisely to drive profitable growth. The company's mission is to build an ideal business-to-business deal management solution. Its products help companies acquire, retain, and serve their customers byworking collaboratively with their trading partners using joined-up plans and incentive programs.Enable was founded in 2016 and is headquartered in San Francisco, California. | $94M / Series C / Oct 18, 2022 | |
|
|
Observe.AI is transforming customer service with AI agents that speak, think, and act like your best human agents—helping enterprises automate routine customer calls and workflows, support agents in real time, and uncover powerful insights from every interaction. With Observe.AI, businesses boost automation, deliver faster, more consistent24/7 service and build stronger customer loyalty. Trusted by brands like SoFi, DoorDash, Uber, Accolade, Prudential, Concentrix, Cox Automotive, and Included Health, Observe.AI is redefining how businesses connect with customers—driving better experiences and lasting relationships at every touchpoint. | $125M / Series C / Apr 12, 2022 | |
|
|
Parade is the leading capacity management platform for freight brokerages. | $12.7M / Series A / Feb 09, 2022 | |
|
|
CloudTrucks develops a virtual trucking carrier application designed to reduce operating costs for truck drivers. The platform helps to manage and book loads from brokers and shippers, offer instant payments after load delivery, and access to cheap insurance options, enabling truck owners and operators to strategize their schedule and design arevenue-maximizing driving program.The company was founded in 2019 and is headquartered in San Francisco, California. | $115M / Series B / Nov 30, 2021 | |
|
|
Enable is a cloud-based software platform that helps distributors, manufacturers, and retailers to calculate, plan, and accrue rebate deals precisely to drive profitable growth. The company's mission is to build an ideal business-to-business deal management solution. Its products help companies acquire, retain, and serve their customers byworking collaboratively with their trading partners using joined-up plans and incentive programs.Enable was founded in 2016 and is headquartered in San Francisco, California. | $45M / Series B / Aug 18, 2021 | |
| See all 15 investments → | |||
Co-Investors
About Menlo Ventures
Menlo Ventures provides capital for multi-stage consumer, enterprise, and life sciences technology companies. Since 1976, the firm’s market-driven analysis has led to the identification of opportunities and successful investments in innovative markets. Notable areas of investment include Marketplaces (Uber, Rover.com, Poshmark); Consumer Services(Tumblr, Betterment, Roku, Siri); Dev/Ops (Harness, Edge Delta, Fire hydrant); SaaS (Carta, ScoutRFP, Qualia, Benchling, Everlaw); Fintech (Betterment, Bluevine, Chime); Cybersecurity (Cavium, IronPort, BitSight, Abnormal, StackRox); and Life Sciences Technology (Synthego, Cofactor Genomics, Recursion Pharmaceuticals, 3T Biosciences). Menlo’s portfolio includes more than 70 public companies, and more than 100 mergers and acquisitions, with $5 billion under management. The firm is currently investing in Menlo Ventures XV, a $500 million early-stage fund, as well as its $500 million Inflection Fund, which targets early-growth investments.
Menlo Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Henry Montgomery
Founder and Partner Emeritus
|
|||
|
Jean-Paul Sanday
Partner
|
|||
|
John Jarve
Partner Emeritus
|
|||
|
Johnny Hu
Principal
|
|||
|
Steve Sloane
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Steve Sloane invest in?
Steve Sloane invests primarily in Artificial Intelligence, SaaS and FinTech startups, most often at Series B and Series C stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Steve Sloane last invest?
The most recent investment recorded for Steve Sloane closed in Jun 2025. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!